268:HKEXKingdee International Software Group Co., Ltd. Analysis
Data as of 2026-05-22 - not real-time
HK$8.70
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Innovax Holdings is trading near its recent support level after a sharp price decline from its mid‑year highs. The stock’s price‑to‑earnings multiple is dramatically above the sector average, reflecting severe overvaluation. Revenue has contracted sharply and operating margins are deeply negative, while cash flow from operations remains in deficit. The company carries a modest debt load but its equity base is thin, leading to a high debt‑to‑equity ratio. No dividend is being paid, eliminating any income component for investors. Technical indicators show the price sitting below both the short‑term moving averages, a bearish MACD histogram, and an RSI that is approaching oversold territory, suggesting limited upside momentum.
Volatility is elevated and beta exceeds one, indicating sensitivity to market swings, while trading volume has been on a downtrend, raising liquidity concerns. The capital‑markets segment faces heightened regulatory scrutiny, adding to sector‑specific risk. Given the combination of extreme valuation, weak fundamentals, and adverse technical signals, the near‑term outlook leans toward further downside, with limited upside potential unless a turnaround materialises.
Volatility is elevated and beta exceeds one, indicating sensitivity to market swings, while trading volume has been on a downtrend, raising liquidity concerns. The capital‑markets segment faces heightened regulatory scrutiny, adding to sector‑specific risk. Given the combination of extreme valuation, weak fundamentals, and adverse technical signals, the near‑term outlook leans toward further downside, with limited upside potential unless a turnaround materialises.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- bearish MACD and price below short‑term averages
- RSI indicating oversold conditions without supporting momentum
- price near recent support with limited upside
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- persistent revenue decline and negative operating margins
- valuation far above industry peers
- absence of dividend and weak cash flow generation
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- structural earnings weakness and high volatility
- elevated regulatory risk in the capital‑markets sector
- ongoing liquidity concerns due to decreasing trading volume
Key Metrics & Analysis
Financial Health
Revenue Growth-87.40%
Profit Margin6.87%
P/E Ratio96.7
ROE2.99%
ROA1.80%
Debt/Equity0.64
P/B Ratio2.5
Op. Cash FlowHK$-29445000
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI32.9
SupportHK$8.51
ResistanceHK$11.50
MA 20HK$9.87
MA 50HK$10.93
MA 200HK$9.82
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.20
Volatility57.59%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.